Yuyue Medical announced the third quarter earnings report

The company released the third quarterly report for 2016: the first three quarters realized revenue of 1.99 billion yuan, up 22.41% year-on-year; realized net profit attributable to 432 million yuan, up 30.11% year-on-year; net profit after deduction was 406 million yuan, up 35.57% year-on-year. Basically in line with expectations.

Growth continued, and the third quarter performance was in line with expectations:

The company's third-quarter financial situation has no consolidated factors, achieving revenue of 572.1 billion yuan, an increase of 5 40% over the same period, achieving a net profit attributable to 1.1 billion yuan, an increase of 25.58% over the same period of last year. The profit growth is significantly higher than the increase in revenue because last year. After the reorganization of the superstructure group in the middle of the year, the profit rate has rebounded significantly. The overall sales expense ratio decreased by 1.1PP compared with the same period of the previous year, and the administrative expenses decreased by nearly 3.2PP. In the first three quarters, the net cash inflow from operations was 411 million yuan, which remained stable.

New product iteration + introduction of machinery, medical equipment product line expansion to enhance competitiveness:

The main driving force for the company's growth comes from the iteration of new products and the acquisition and acquisition of the products. In terms of new products, the market for sleep ventilators introduced last year was highly accepted, with approximately 7,000 units sold through e-commerce and offline channels, corresponding to approximately 30 million in revenue. In addition, indwelling needles and vacuum blood collection tubes are also being promoted in the hospital market. After the completion of the acquisition of Shanghai Machinery Group, the company's product line for surgical instruments and sanitary materials has been greatly expanded, and the vitality of the machinery factory has been re-energized by means of reducing staff and increasing efficiency, improving production lines and reorganizing sales channels. It is estimated that more than 400 million yuan of income will be realized in the first three quarters, and the net interest rate will reach 10% or more. The effect of restructuring is obvious. In addition, the company's second-stage production bases in Danyang and Suzhou are under construction and are expected to be put into use within 2-3 years, which will help improve product supply capacity and increase gross profit margin.

The German subsidiary is put into operation and the internationalization strategy is moving forward:

The German subsidiary, which the company plans to set up in April, was officially put into operation in late September. The event marks an important step in the internationalization strategy of Diving. The German subsidiary in the manufacturing and commercial center Tuttlingen plays a two-way role in the future development of the fish jump: on the one hand, the company will introduce overseas advanced products and manufacturing technology into the country through subsidiaries, strengthen its own manufacturing level and enhance its products. On the other hand, the German subsidiary will also become a window for the development of the company's products in Europe, increasing overseas sales.

Product expansion step by step, cooperation into the hospital supply chain to enhance the viscosity, maintain a "strongly recommended" rating: the company through independent research and development, mergers and acquisitions and other ways to continue to expand product lines, leading the development of domestic medical and health needs, and efficient production capacity and promotion capabilities Rapid product adoption. The company cooperated with Kyushu to build a hospital supply chain, provide information systems and try to host equipment and consumables, further strengthen user stickiness and strengthen channel relationships.

Soba Noodles

Soba Noodle,Tartary Buckwheat,Sesame Soba Noodles,Soba Cup Noodles

Huantai Biotechnology Co., Ltd. , https://www.huantaifds.com